Collection & Ordering

How it works

The Envisia classifier provides a more confident IPF diagnosis and ILD prognosis.
Scientific illustration of lungs with a close-up of a bronchoscopy brushing lung tissue and a test tube
Envisia_Collection-Ordering_Step1

Collect patient samples

3-5 samples are collected using standard TBB forceps and shipped to Veracyte.
Photo of an open Veractye Nanocool Sample collection box

Ship to Veracyte

Veracyte provides sample collection kit and FedEx shipping from collection site to Veractye lab.

A smart phone showing the test results for an Envisia test. In the example, the test is positive and text interpretation is provided with references.

Online results

Results are available within 2 weeks on the Veracyte online portal and mobile app.
Play Video about Envisia Genomic Classifier Kit Package

Envisia collection and reporting

Watch the collection video to hear about the easy process to collect a patient sample and order the Envisia test.

Who is a good candidate for Envisia?

Clinical Factors:

Have no known causes identified with suspected ILD

HRCT:

Probable UIP or indeterminate for UIP

Tolerability:

Able to tolerate standard TBBx procedure

Result interpretation

Envisia classifier results indicate either a positive or negative for UIP.

Positive results

Screenshot of a patient report showing a negative Envisia test. Includes patient information and the result.
A positive result can give clinicians confidence that there is high likelihood of UIP given the high specificity of test and low likelihood of a false positive result.1

Negative results

Screenshot of a patient report showing a positive Envisia test. Includes patient information and the result.
A negative result can provide useful information in context of clinical factors and HRCT. Continued ILD diagnosis workup may be needed.

Viewing test reports

Test results delivered within two weeks to your computer or phone.
A smart phone showing the test results for an Envisia test. In the example, the test is positive and text interpretation is provided with references.

Access practice trend reports and sample testing status​

View your Veracyte portal to get practice insights, track trends, and better understand your patients.

 

Your Home Dashboard illustrates:

  • Samples submitted and status report (Reported / Processing / Not Ordered)
  • Order history
  • Result breakdown by test result. Patient results are available within two weeks.

 

If you want to learn more or would like a walk through of your dashboard please contact our customer care team at 844.464.LUNG 844.464.5864 support@veracyte.com.

Covered by Medicare

The Envisia test is covered by Medicare. Veracyte bills Medicare and third-party payers directly.

 

The Veracyte Access Program provides financial support for both eligible uninsured and commercially available insured patients with financial need.

Frequently Asked Questions

Results for the Envisia Genomic Classifier are available within two weeks after the test order is confirmed.

Results can be accessed on the Veracyte online portal and mobile app.

Samples should be packaged and shipped to Veracyte on the same day as collected, using the provided shipper and return shipping labels.

Samples should be shipped the same day via FedEx®. Return label is pre-applied to the provided shipping box. If you do not have a routine pickup, call FedEx at 1.800.GOFEDEX (1.800.463.3339) to schedule one.

References

1. Raghu G, et al. Lancet Respiratory Medicine. Apr 2019.